The serum NF-kB levels of hypothyroid patients with HT who did not receive levothyroxine treatment were similar to those in the group that received replacement therapy, which may support the idea that levothyroxine replacement does not change the autoimmune process in the thyroid gland, despite its many physiological effects. The gene discussed is NFKB1; the disease is hematocrit.